Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250923067343N5Phase 3Completed
Phase 3 trial of magnesium, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Primary anesthetic drug requirement. Started Apr 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250923067343N5.